Laurent Derré Selected Research

Non-Muscle Invasive Bladder Neoplasms

12/2021	Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients.
1/2020	Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
1/2019	Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer Model.
11/2018	Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy.
11/2017	[Immunotherapy : a revolution in the management of urothelial bladder cancer ?]
8/2017	ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
2/2017	Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
1/2017	Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
7/2016	Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.
7/2015	Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Derré Research Topics

Disease

27	Neoplasms (Cancer) 02/2022 - 03/2004
12	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2014
11	Non-Muscle Invasive Bladder Neoplasms 12/2021 - 01/2014
7	Melanoma (Melanoma, Malignant) 02/2013 - 12/2003
3	Typhoid Fever (Typhoid) 01/2019 - 07/2015
2	Infections 01/2020 - 11/2018
2	Testicular Neoplasms (Testicular Cancer) 01/2011 - 09/2008
2	Breast Neoplasms (Breast Cancer) 07/2009 - 03/2004
1	Prostatic Neoplasms (Prostate Cancer) 02/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Ovarian Epithelial Carcinoma 01/2018
1	Carcinoma in Situ 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Virus Diseases (Viral Diseases) 01/2010
1	Human Influenza (Influenza) 06/2009

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2020 - 12/2003
9	AntigensIBA 01/2020 - 12/2003
8	Peptides (Polypeptides)IBA 10/2015 - 12/2003
5	Neoplasm Antigens (Tumor Antigens)IBA 07/2015 - 03/2004
4	LigandsIBA 01/2022 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 03/2004
4	CytokinesIBA 01/2019 - 07/2009
4	EpitopesIBA 01/2018 - 12/2003
4	MART-1 AntigenIBA 06/2012 - 12/2003
4	HLA-A*02:01 antigenIBA 06/2009 - 12/2003
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2018
2	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2022 - 12/2021
2	Bacterial VaccinesIBA 01/2019 - 07/2015
2	InterferonsIBA 11/2018 - 03/2014
2	Cancer VaccinesIBA 02/2017 - 03/2004
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022
1	LectinsIBA 01/2022
1	Sialic AcidsIBA 12/2021
1	Polysaccharides (Glycans)IBA 12/2021
1	Cell Surface ReceptorsIBA 01/2020
1	AntibodiesIBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Recombinant ProteinsIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 10/2019
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2019
1	Interleukin-13IBA 08/2017
1	BCG Vaccine FDA Link 08/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2017
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2016
1	Thymidine KinaseIBA 07/2016
1	ProdrugsIBA 07/2016
1	Immunoglobulin FragmentsIBA 04/2013
1	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 10/2009
1	HLA-DQ6 antigenIBA 10/2009
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2009
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 06/2009
1	Granzymes (Granzyme)IBA 06/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2004
1	HLA-A Antigens (HLA-A)IBA 03/2004
1	Monophenol Monooxygenase (Tyrosinase)IBA 12/2003
1	HLA-B Antigens (HLA-B)IBA 12/2003

Therapy/Procedure

11	Therapeutics 12/2021 - 08/2012
11	Immunotherapy 01/2020 - 12/2007
2	Intravesical Administration 01/2019 - 01/2014
1	Injections 02/2017